ABOUT ASCEND & ABL INC.

Ascend Advanced Therapies (Ascend) is a gene-to-GMP contract, development, and manufacturing organization (CDMO) built on decades of biomedical research and therapeutic development expertise.

Capabilities span early-stage discovery work, optimization, process development, regulatory support, and drug-substance to GMP manufacturing. The company started with a specialty focus on gene therapies across AAV serotypes going back to 1991. In late 2024, Ascend and ABL, Inc. partnered to leverage 60+ years of expertise across a broad spectrum of viral vectors. The alignment further expanded the United States footprint and specialized offering to include government and public R&D to GMP manufacturing of gene therapies, immunotherapies, oncolytics, and vaccines.

Together, the teams support customers from research to commercial scale through to fill/finish capabilities in both US locations. Understanding the challenges developers face today, the team is continuously evolving the technology platform featuring an extensive analytical portfolio of >50 in-house characterization and release assays. Full-scale GMP facilities in Rockville, MD and Alachua, FL are complemented by GMP QC capabilities in Munich, Germany (EU).

INDUSTRY INSIGHTS

CONTACT INFORMATION

Ascend & ABL Inc.

9800 Medical Center Dr D

Rockville, MD 20850

UNITED STATES

SOLUTIONS

  • What We Do

    Ascend is the partner for AAV vector design, manufacturability, scale-up and quality assurance. From early pre-clinical phases into the clinic and out on the market, we understand that consistent product quality is not negotiable and work to get it right early on. Our team is always thinking about the scalability of a product to ensure it can have the greatest impact on the patients that need it.

  • Outsourcing: A Way To Help Your Team Overcome Challenges

    Partnering with us provides immediate access to a skilled CMC team with decades of experience across serotypes and production scales.

POSTERS